Robert Rifkin, MD, Hematologist/Oncologist, Associate Chair, US Oncology Hematology Research, Rocky Mountain Cancer Centers, Discusses Clinical Data That Could Change The Way MM Is Treated. At The 60th ASH Annual Meeting on Dec 1, 2018. http://obroncology.com
Clinical Data That Could Change The Way MM Is Treated
